Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
Links shared publicly online about this topic.
- 875total visits
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
View full resource at drugs.com
Tags: Schizophrenia, Antipsychotic Medication, Psychotic Disorder, Disease and Condition, Drug, FDA, Merck & Co.
Most Recently Shared on September 14, 2010 at 1:14 am By:
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asen... http://bit.ly/cBfzbG #drug
Merck Receives Approval From FDA For Expanded Indications For
pharmaceuticalonline.com — “Merck Receives Approval From FDA For Expanded Indications For Atypical Antipsychotic Medication SAPHRIS (Asenapine) Sublingual Tablets - Merck” View full resource at pharmaceuticalonline.com
Most Recently Shared on September 9, 2010 at 3:21 pm By:
Peter H Brown Doctor and Psychologist
Merck Receives Approval From FDA For Expanded Indications For http://bit.ly/b9iass #psychosis #schizo
PharmaLive: Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
pharmalive.com — “PharmaLive: Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets” View full resource at pharmalive.com
Most Recently Shared on September 7, 2010 at 3:17 pm By:
Peter H Brown Doctor and Psychologist
Merck Receives Approval from FDA for Expanded Indications for Atypical ... http://bit.ly/cmmHON #bipolar
Advertisement
